Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Enlight Media Co Ltd
SZSE:300251
|
CN |
Cosmos Pharmaceutical Corp
Total Receivables
Cosmos Pharmaceutical Corp
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Total Receivables
¥801m
|
CAGR 3-Years
33%
|
CAGR 5-Years
56%
|
CAGR 10-Years
39%
|
|
|
Sundrug Co Ltd
TSE:9989
|
Total Receivables
¥32.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Total Receivables
¥122.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
29%
|
CAGR 10-Years
22%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Total Receivables
¥87.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
20%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Total Receivables
¥71.7B
|
CAGR 3-Years
24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Total Receivables
¥75.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Cosmos Pharmaceutical Corp
Glance View
In the bustling landscape of Japan's healthcare and beauty industry, Cosmos Pharmaceutical Corp. stands out as a compelling story of strategic ambition and adaptive growth. Established in 1976, the company emerged in Fukuoka, swiftly evolving from a traditional pharmacy into one of the country's most recognized chains of drugstores. Cosmos carved its niche by blending the conveniences of modern retailing with a diverse array of pharmaceutical, health, and personal care products. It's not merely a matter of selling medication; Cosmos transformed the drugstore experience, offering a comprehensive range of products including cosmetics, daily essentials, and food items, which cater to the holistic needs of its customers. This diversification strategy bolsters revenue streams and mitigates risks associated with dependency on any single product category. The company's financial success is further driven by its efficient use of technology and economy of scale. Cosmos Pharmaceutical masterfully implements IT solutions and logistics optimization to manage its expansive network of stores, which number in the thousands across Japan. This not only reduces operational costs but also ensures timely restocking, enhancing consumer satisfaction. The chain's "Everyday Low Pricing" strategy is pivotal to its profitability, drawing in cost-conscious customers and fostering high sales volume. By maintaining streamlined operations and a customer-centric approach, Cosmos cultivates a symbiotic relationship between growth and efficiency, allowing it to thrive in a competitive market and continue its expansion across Japan.
See Also
What is Cosmos Pharmaceutical Corp's Total Receivables?
Total Receivables
801m
JPY
Based on the financial report for Feb 28, 2026, Cosmos Pharmaceutical Corp's Total Receivables amounts to 801m JPY.
What is Cosmos Pharmaceutical Corp's Total Receivables growth rate?
Total Receivables CAGR 10Y
39%
Over the last year, the Total Receivables growth was 19%. The average annual Total Receivables growth rates for Cosmos Pharmaceutical Corp have been 33% over the past three years , 56% over the past five years , and 39% over the past ten years .